Elsevier Inc.

SHERPA: Unknown

People

  1. Kernan
    Kernan
  2. O'Reilly
    O'Reilly
  3. Scaradavou
    Scaradavou
  4. Perales
    Perales
  5. Papadopoulos
    Papadopoulos
  6. Young
    Young
  7. Castro-Malaspina
    Castro-Malaspina
  8. Jakubowski
    Jakubowski
  9. Giralt
    Giralt
  10. Ponce
    Ponce

Groups

  1. Center for Hematologic Malignancies (47)
  2. Pediatrics, Department of (47)
  3. Stem Cell Transplantation and Cellular Therapy Service (47)
  4. Department of Medicine (45)
  5. Hematologic Malignancies, Division of (37)
  6. Bone Marrow Transplant (36)
  7. Tow Center for Developmental Oncology (TCDO) (36)
  8. GSK Faculty (35)
  9. Immunology Program Faculty (35)
  10. Sloan Kettering Institute Faculty (35)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Susan Prockop"
Formats
  1. Meeting Abstract (34)
  2. Journal Article (12)
  3. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (47)
  2. Pediatrics, Department of (47)
  3. Stem Cell Transplantation and Cellular Therapy Service (47)
  4. Department of Medicine (45)
  5. Hematologic Malignancies, Division of (37)
  6. Bone Marrow Transplant (36)

More Groups

People
  1. Susan Prockop (47)
  2. Nancy Kernan (35)
  3. Richard O'Reilly (34)
  4. Farid Boulad (29)
  5. Andromachi Scaradavou (28)
  6. Miguel-Angel Perales (26)

More People

Years
  1. 2022 (3)
  2. 2021 (1)
  3. 2020 (5)
  4. 2019 (4)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (42)
  2. Transplantation and Cellular Therapy (4)
  3. International Journal of Radiation Oncology, Biology, Physics (1)

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim results of a pilot, prospective, randomized, double-blinded, vehicle-controlled trial on safety and efficacy of a topical inhibitor of Janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non-sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease
    Meeting Abstract

    Markova, A.; Prockop, S. E.; Dusza, S.; Pan, A.; Chowdhury, A.; Lacouture, M. E.; Perales, M. A.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Noninvasive genomic characterization of patients with nonsclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease identified a novel gene signature in responders to ruxolitinib cream
    Meeting Abstract

    Markova, A.; Whitaker, J. W.; Ai, R.; Pan, A.; Dusza, S.; Lacouture, M. E.; Chowdhury, A.; Perales, M. A.; Prockop, S. E.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Real-time reflectance confocal microscopy of cutaneous graft-versus-host disease correlates with histopathology
    Journal Article

    Reingold, R. E.; Monnier, J.; Ardigò€, M.; Stoll, J. R.; Pena, M. C.; Nanda, J. K.; Dusza, S. W.; Ruiz, J. D.; Flynn, L.; Afrin, A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: A report on behalf of the American Society for Transplantation and Cellular Therapy
    Guidelines

    Kharfan-Dabaja, M. A.; Kumar, A.; Ayala, E.; Aljurf, M.; Nishihori, T.; Marsh, R.; Burroughs, L. M.; Majhail, N.; Al-Homsi, A. S.; Al-Kadhimi, Z. S.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Early CD4+ T cell reconstruction as predictor for outcomes after allogeneic hematopoietic cell transplantation in pediatric and young adult patients: A validation cohort analyses
    Meeting Abstract

    Van Roessel, I.; Prockop, S. E.; Klein, E.; Boulad, F.; Scaradavou, A.; Spitzer, B.; Kung, A.; Curran, K.; Cancio, M.; O'Reilly, R. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Blinatumomab as a successful bridge to hematopoietic stem cell transplant in a down syndrome patient with relapsed B-precursor acute lymphoblastic leukemia
    Meeting Abstract

    Smith, M. H.; Steinherz, P. G.; Shukla, N.; Forlenza, C. J.; Prockop, S. E.; Ramaswamy, K.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save